Drug Enforcement D-0561-2023

CGMP deviations.

Status

Terminated

Classification

Class II

Report Date

May 10, 2023

Termination Date

April 30, 2024

Product Information

Product description
Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottle (NDC 43063-0726-30) b) 90 count-bottle (NDC 43063-0726-90)
Product quantity
393 bottles
Reason for recall
CGMP deviations.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide in the US.

Location & Firm

Recalling firm
PD-Rx Pharmaceuticals, Inc.
Address
727 N Ann Arbor Ave

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0561-2023
Event ID
92081
Recall initiation date
April 6, 2023
Center classification date
May 1, 2023
Code info
Lots: a) A22A17, D22C21 Exp. 07/31/23; K22D89, L22B26, L22D14 Exp. 03/31/24; L22D96 Exp. 04/30/24; b) L21E06 Exp. 05/31/23; B22C05, D22B91, E22C82 Exp. 07/31/23; G22B03 G22B79, H22A30, J22B81 Exp. 08/31/23; J22F27, K22B37, K22B88 Exp. 10/31/23; L22D32 Exp. 03/31/24; B23E07 Exp. 04/30/24
More code info